| . | Disease subtype . | Age . | Male . | Female . | Total . | Reference . |
|---|---|---|---|---|---|---|
| Patient samples | Spindle cell RMS | Pediatric (<20 yr old) | 3 | 0 | 3 | Present study (Biomax SO2082a) |
| Adult (>20 yr old) | 11 | 1 | 12 | Present study (Biomax SO2082a) | ||
| Pleomorphic RMS | Pediatric (<20 yr old) | 3 | 0 | 3 | Present study (Biomax SO2082a) | |
| Adult (>20 yr old) | 18 | 9 | 27 | Present study (Biomax SO2082a) | ||
| Embryonal RMS | Pediatric (mean age, 6.6 yr) | Unknown | Unknown | 59 | Grass et al., 2009 | |
| Pediatric (mean age, 5.7 yr) | Unknown | Unknown | 33 | Ganti et al., 2006 | ||
| Pediatric (5–19 yr old) | Unknown | Unknown | 173 | Wachtel et al., 2006 | ||
| Pediatric (<20 yr old) | 5 | 5 | 10 | Present study (Biomax SO2082a) | ||
| Adult (>20 yr old) | 8 | 9 | 17 | Present study (Biomax SO2082a) | ||
| Alveolar RMS | Pediatric (mean age, 6.6 yr) | Unknown | Unknown | 21 | Grass et al., 2009 | |
| Pediatric (mean age, 5.7 yr) | Unknown | Unknown | 35 | Ganti et al., 2006 | ||
| Pediatric (5–19 yr old) | Unknown | Unknown | 47 | Wachtel et al. | ||
| Pediatric (<20 yr old) | 5 | 5 | 10 | Present study (Biomax SO2082a) | ||
| Adult (>20 yr old) | 8 | 9 | 17 | Present study (Biomax SO2082a) | ||
| Skeletal muscle (control) | Pediatric | 0 | 1 | 1 | Present study (Biomax SO2082a) | |
| Adult | 7 | 1 | 8 | Present study (Biomax SO2082a) | ||
| Cell line | Embryonal RMS | Pediatric | – | – | 2 | RD, SMS-CTR |
| Alveolar RMS | Pediatric | – | – | 2 | Rh30, Rh41 | |
| PDX | Embryonal RMS | Pediatric | – | – | 8 | |
| Alveolar RMS | Pediatric | – | – | 4 |
| . | Disease subtype . | Age . | Male . | Female . | Total . | Reference . |
|---|---|---|---|---|---|---|
| Patient samples | Spindle cell RMS | Pediatric (<20 yr old) | 3 | 0 | 3 | Present study (Biomax SO2082a) |
| Adult (>20 yr old) | 11 | 1 | 12 | Present study (Biomax SO2082a) | ||
| Pleomorphic RMS | Pediatric (<20 yr old) | 3 | 0 | 3 | Present study (Biomax SO2082a) | |
| Adult (>20 yr old) | 18 | 9 | 27 | Present study (Biomax SO2082a) | ||
| Embryonal RMS | Pediatric (mean age, 6.6 yr) | Unknown | Unknown | 59 | Grass et al., 2009 | |
| Pediatric (mean age, 5.7 yr) | Unknown | Unknown | 33 | Ganti et al., 2006 | ||
| Pediatric (5–19 yr old) | Unknown | Unknown | 173 | Wachtel et al., 2006 | ||
| Pediatric (<20 yr old) | 5 | 5 | 10 | Present study (Biomax SO2082a) | ||
| Adult (>20 yr old) | 8 | 9 | 17 | Present study (Biomax SO2082a) | ||
| Alveolar RMS | Pediatric (mean age, 6.6 yr) | Unknown | Unknown | 21 | Grass et al., 2009 | |
| Pediatric (mean age, 5.7 yr) | Unknown | Unknown | 35 | Ganti et al., 2006 | ||
| Pediatric (5–19 yr old) | Unknown | Unknown | 47 | Wachtel et al. | ||
| Pediatric (<20 yr old) | 5 | 5 | 10 | Present study (Biomax SO2082a) | ||
| Adult (>20 yr old) | 8 | 9 | 17 | Present study (Biomax SO2082a) | ||
| Skeletal muscle (control) | Pediatric | 0 | 1 | 1 | Present study (Biomax SO2082a) | |
| Adult | 7 | 1 | 8 | Present study (Biomax SO2082a) | ||
| Cell line | Embryonal RMS | Pediatric | – | – | 2 | RD, SMS-CTR |
| Alveolar RMS | Pediatric | – | – | 2 | Rh30, Rh41 | |
| PDX | Embryonal RMS | Pediatric | – | – | 8 | |
| Alveolar RMS | Pediatric | – | – | 4 |